皮肤疾病光动力治疗的光源和照光参数选择

doi:10.35541/cjd.20200041

中华皮肤科杂志 ›› 2021, Vol. 54 ›› Issue (11): 1015-1018.doi: 10.35541/cjd.20200041

皮肤疾病光动力治疗的光源和照光参数选择

刘沛石磊王秀丽

同济大学附属皮肤病医院上海市皮肤病医院光医学研究所，上海 200092

收稿日期:2020-01-16 修回日期:2020-08-05 发布日期:2021-11-01
通讯作者: 王秀丽 E-mail:wangxiuli_1400023@tongji.edu.cn
基金资助:
上海申康医院发展中心临床科技创新项目（SHDC12019130）

Selection of light sources and radiation parameters in photodynamic therapy for skin diseases

Liu Pei, Shi Lei, Wang Xiuli

Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200092, China

Received:2020-01-16 Revised:2020-08-05 Published:2021-11-01
Contact: Wang Xiuli E-mail:wangxiuli_1400023@tongji.edu.cn
Supported by:
Shanghai Shen-Kang Hospital Development Center for Clinical Technology Innovation Project（SHDC12019130）

摘要/Abstract

摘要： 【摘要】光动力治疗（PDT）是日光性角化病、尖锐湿疣和中重度寻常痤疮等难治性皮肤疾病的一线治疗方法。临床应用中照光参数和光源对PDT疗效有着重要影响。本文着重从光源波长、光源类型、照光剂量几方面阐述PDT中如何设定照光参数和选择光源，并综述新型PDT光源的研究进展。

关键词: 光化学疗法, 皮肤疾病, 照光参数, 光源

Abstract: 【Abstract】 Photodynamic therapy （PDT） is the first?line treatment of some intractable skin diseases, such as actinic keratosis, condyloma acuminatum and moderate to severe acne vulgaris. In clinical practice, radiation parameters and light sources are important for the efficacy of PDT. This review focuses on the selection of radiation parameters and light sources for PDT in terms of the wavelength and type of light sources and dose of radiation, and summarizes research progress in new light sources for PDT.

Key words: Photochemotherapy, Skin diseases, Radiation parameters, Light sources

刘沛石磊王秀丽. 皮肤疾病光动力治疗的光源和照光参数选择[J]. 中华皮肤科杂志, 2021,54(11):1015-1018. doi:10.35541/cjd.20200041

Liu Pei, Shi Lei, Wang Xiuli. Selection of light sources and radiation parameters in photodynamic therapy for skin diseases[J]. Chinese Journal of Dermatology, 2021, 54(11): 1015-1018.doi:10.35541/cjd.20200041

参考文献 29

［1］	中华医学会皮肤性病学分会光动力治疗研究中心. 氨基酮戊酸光动力疗法临床应用专家共识［J］. 中华皮肤科杂志, 2015,48（10）:675⁃678. doi: 10.3760/cma.j.issn.0412⁃4030.2015. 10.001.
［2］	Kwiatkowski S, Knap B, Przystupski D, et al. Photodynamic therapy ⁃ mechanisms, photosensitizers and combinations［J］. Biomed Pharmacother, 2018,106:1098⁃1107. doi: 10.1016/j.biopha.2018.07.049.
［3］	Morton CA, Szeimies RM, Basset⁃Séguin N, et al. European Dermatology Forum Guidelines on topical photodynamic therapy 2019 Part 2: emerging indications ⁃ field cancerization, photorejuvenation and inflammatory/infective dermatoses［J］. J Eur Acad Dermatol Venereol, 2020,34（1）:17⁃29. doi: 10.1111/jdv.16044.
［4］	Wong TH, Morton CA, Collier N, et al. British Association of Dermatologists and British Photodermatology Group guidelines for topical photodynamic therapy 2018［J］. Br J Dermatol, 2019,180（4）:730⁃739. doi: 10.1111/bjd.17309.
［5］	Wang XL, Wang HW, Huang Z, et al. Study of protoporphyrin IX （PpIX） pharmacokinetics after topical application of 5⁃aminolevulinic acid in urethral condylomata acuminata［J］. Photochem Photobiol, 2007,83（5）:1069⁃1073. doi: 10.1111/j.1751⁃1097.2007.00178.x.
［6］	LaRochelle E, Marra K, LeBlanc RE, et al. Modeling PpIX effective light fluence at depths into the skin for PDT dose comparison［J］. Photodiagnosis Photodyn Ther, 2019,25:425⁃435. doi: 10.1016/j.pdpdt.2019.01.022
［7］	Lei TC, Glazner GF, Duffy M, et al. Optical properties of hematoporphyrin monomethyl ether （HMME）, a PDT photosensitizer［J］. Photodiagnosis Photodyn Ther, 2012,9（3）:232⁃242. doi: 10.1016/j.pdpdt.2012.01.003.
［8］	Zhang Y, Zou X, Chen H, et al. Clinical study on clinical operation and post⁃treatment reactions of HMME⁃PDT in treatment of PWS［J］. Photodiagnosis Photodyn Ther, 2017,20:253⁃256. doi: 10.1016/j.pdpdt.2017.09.013.
［9］	Li DC, Nong X, Hu ZY, et al. Efficacy and related factors analysis in HMME⁃PDT in the treatment of port wine stains［J］. Photodiagnosis Photodyn Ther, 2020,29:101649. doi: 10.1016/j.pdpdt.2020.101649.
［10］	Tang Y, Xie H, Li J, et al. The association between treatment reactions and treatment efficiency of Hemoporfin⁃photodynamic therapy on port wine stains: a prospective double blind randomized controlled trial［J］. Photodiagnosis Photodyn Ther, 2017,18:171⁃178. doi: 10.1016/j.pdpdt.2017.02.005.
［11］	Jamali Z, Hejazi SM, Ebrahimi SM, et al. Effects of LED⁃based photodynamic therapy using red and blue lights, with natural hydrophobic photosensitizers on human glioma cell line［J］. Photodiagnosis Photodyn Ther, 2018,21:50⁃54. doi: 10.1016/j.pdpdt.2017.11.002.
［12］	Brancaleon L, Moseley H. Laser and non⁃laser light sources for photodynamic therapy［J］. Lasers Med Sci, 2002,17（3）:173⁃186. doi: 10.1007/s101030200027.
［13］	Etcheverry ME, Pasquale MA, Garavaglia M. Photodynamic therapy of HeLa cell cultures by using LED or laser sources［J］. J Photochem Photobiol B, 2016,160:271⁃277. doi: 10.1016/j.jphotobiol.2016.04.013.
［14］	Michelini M. Photodynamic therapy activated by intense pulsed light in the treatment of actinic keratosis［J］. G Ital Dermatol Venereol, 2020,155（4）:470⁃476. doi: 10.23736/S0392⁃0488. 18.05894⁃7.
［15］	Zhang L, Wu Y, Zhang Y, et al. Topical 5⁃aminolevulinic photodynamic therapy with red light vs intense pulsed light for the treatment of acne vulgaris: a spilit face, randomized, prospective study［J］. Dermatoendocrinol, 2017,9（1）:e1375634. doi: 10.1080/19381980.2017.1375634.
［16］	Requena MB, Vollet Filho JD, Barboza de Nardi A, et al. Topical and intradermal delivery of PpIX precursors for photodynamic therapy with intense pulsed light on porcine skin model［J］. Lasers Med Sci, 2019,34（9）:1781⁃1790. doi: 10.1007/s10103⁃019⁃02771⁃y.
［17］	Hass R, Jacobs R, Kaufmann AM, et al. Sensitization of immune cells following hexylaminolevulinate photodynamic therapy of cervical intraepithelial neoplasia［J］. Photodiagnosis Photodyn Ther, 2017,17:82⁃86. doi: 10.1016/j.pdpdt.2016.11.006.
［18］	Ozog DM, Rkein AM, Fabi SG, et al. Photodynamic therapy: a clinical consensus guide［J］. Dermatol Surg, 2016,42（7）:804⁃827. doi: 10.1097/DSS.0000000000000800.
［19］	Sakamoto FH, Lopes JD, Anderson RR. Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part I. Acne vulgaris: when and why consider photodynamic therapy?［J］. J Am Acad Dermatol, 2010,63（2）:183⁃193; quiz 193⁃194. doi: 10.1016/j.jaad.2009.09.056.
［20］	Morton CA, Braathen LR. Daylight Photodynamic therapy for actinic keratoses［J］. Am J Clin Dermatol, 2018,19（5）:647⁃656. doi: 10.1007/s40257⁃018⁃0360⁃y.
［21］	Ibbotson S, Stones R, Bowling J, et al. A consensus on the use of daylight photodynamic therapy in the UK［J］. J Dermatolog Treat, 2017,28（4）:360⁃367. doi: 10.1080/09546634.2016.1240863.
［22］	Mordon S, Vignion⁃Dewalle AS, Thecua E, et al. Can daylight⁃PDT be performed indoor?［J］. G Ital Dermatol Venereol, 2018,153（6）:811⁃816. doi: 10.23736/S0392⁃0488.18.05907⁃2.
［23］	Larochelle E, Chun HH, Hasan T, et al. Multi⁃spectral wide⁃field imaging for PplX PDT dosimetry of skin［C/OL］//Spie Bios, San Francisco, California, 2016［2020⁃08⁃14］. https://www.spiedigitallibrary.org/conference⁃proceedings⁃of⁃spie/9694/1/Multi⁃spectral⁃wide⁃field⁃imaging⁃for⁃PplX⁃PDT⁃dosimetry⁃of/10.1117/12.2213463.full?SSO=1. doi: 10.1117/12.2213463.
［24］	Attili SK, Lesar A, McNeill A, et al. An open pilot study of ambulatory photodynamic therapy using a wearable low⁃irradiance organic light⁃emitting diode light source in the treatment of nonmelanoma skin cancer［J］. Br J Dermatol, 2009,161（1）:170⁃173. doi: 10.1111/j.1365⁃2133.2009.09096.x.
［25］	Mordon S, Cochrane C, Tylcz JB, et al. Light emitting fabric technologies for photodynamic therapy［J］. Photodiagnosis Photodyn Ther, 2015,12（1）:1⁃8. doi: 10.1016/j.pdpdt.2014.11. 002.
［26］	Masuda H, Kimura M, Nishioka A, et al. Dual wavelength 5⁃aminolevulinic acid photodynamic therapy using a novel flexible light⁃emitting diode unit［J］. J Dermatol Sci, 2019,93（2）:109⁃115. doi: 10.1016/j.jdermsci.2018.12.006.
［27］	Lucky SS, Soo KC, Zhang Y. Nanoparticles in photodynamic therapy［J］. Chem Rev, 2015,115（4）:1990⁃2042. doi: 10.1021/cr5004198.
［28］	Liu P, Yang W, Shi L, et al. Concurrent photothermal therapy and photodynamic therapy for cutaneous squamous cell carcinoma by gold nanoclusters under a single NIR laser irradiation［J］. J Mater Chem B, 2019,7（44）:6924⁃6933. doi: 10.1039/c9tb01573f.
［29］	Shi L, Liu P, Wu J, et al. The effectiveness and safety of X⁃PDT for cutaneous squamous cell carcinoma and melanoma［J］. Nanomedicine （Lond）, 2019,14（15）:2027⁃2043. doi: 10.2217/nnm⁃2019⁃0094.

[1]	张国毅, 龚向东, 朱伯堃, 柳传霞, 景玲华, 徐金玉. 2019年中国医学科学院皮肤病医院门诊病种分析[J]. 中华皮肤科杂志, 2022, 55(2): 150-152.
[2]	姜沛彧张嘉文刘子菁王小燕刘韵祎刘乙萱许阳. 光生物调节的基本原理及其在皮肤科的应用[J]. 中华皮肤科杂志, 2022, 55(1): 84-87.
[3]	中华医学会皮肤性病学分会中国医师协会皮肤科医师分会. 自身免疫性表皮下大疱病诊疗共识（2022）[J]. 中华皮肤科杂志, 2022, 55(1): 1-11.
[4]	龙海蒋丽邱月棨姚南刘力聪谢昱明熊峰谭思齐匡琪琪尤睿璇柴可罗鑫龙浩君忻悦郭子瑜王佳琪谭怡忻张庆张桂英李亚萍苏玉文肖嵘陆前进, . 皮肤科病房危重症1 057例临床分析[J]. 中华皮肤科杂志, 2021, 54(9): 790-797.
[5]	胡枫陈柳青王巍郑芳. COVID-19流行期间武汉某医院皮肤科门诊患者流行病学特点及疾病谱分析[J]. 中华皮肤科杂志, 2021, 54(8): 719-722.
[6]	应洁雅相文忠宋秀祖. 代谢综合征与皮肤病[J]. 中华皮肤科杂志, 2021, 54(7): 642-645.
[7]	中国医师协会皮肤科医师分会自身免疫病专业委员会. 甲氨蝶呤治疗免疫相关性皮肤病专家共识[J]. 中华皮肤科杂志, 2021, 54(5): 382-390.
[8]	胡燕燕姜倩陈柳青李东升. 反射式共聚焦显微镜在海姆泊芬光动力疗法治疗紫红型鲜红斑痣疗效评估中的应用[J]. 中华皮肤科杂志, 2021, 54(4): 342-346.
[9]	叶瑞贤薛如君梁景耀刘焕颜熊绮颖董良娇张锡宝. microRNA在炎症性皮肤病中作用的研究进展[J]. 中华皮肤科杂志, 2021, 54(2): 178-182.
[10]	朱蓓蓓李婧黄慧瑶李宁刘利军张丽华宦静倪琪侯伟刘毅杨雪源. 2020年中国皮肤病药物临床试验分析[J]. 中华皮肤科杂志, 2021, 54(11): 1001-1004.
[11]	郑玉灿孔桂萍金玉李玫. FAM111B基因突变致遗传性纤维性皮肤异色病伴跟腱挛缩、肌病和肺纤维化一例[J]. 中华皮肤科杂志, 2021, 54(11): 973-977.
[12]	郑哲张国龙, 王佩茹, 吉杰, 王秀丽, . 氨基酮戊酸光动力疗法治疗前后SKH-1小鼠皮肤鳞状细胞癌组织中免疫细胞亚群变化[J]. 中华皮肤科杂志, 2021, 54(11): 978-983.
[13]	金双黄丹陈崑. 日光光动力疗法在光线性角化病的临床应用进展[J]. 中华皮肤科杂志, 2021, 54(11): 1023-1027.
[14]	陈伟谢恒李利. 胞外囊泡在皮肤科的研究进展和应用前景[J]. 中华皮肤科杂志, 2021, 54(10): 910-914.
[15]	李容, 张家安, 陈崑. 玫瑰痤疮光电疗法研究进展[J]. 中华皮肤科杂志, 2021, 0(1): 20201002-e20201002.

皮肤疾病光动力治疗的光源和照光参数选择

Selection of light sources and radiation parameters in photodynamic therapy for skin diseases

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 29

相关文章 15

Metrics

本文评价

推荐阅读 10